Accendra Health, Inc.
ACH
$3.23
$0.072.22%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -195.84% | -203.47% | -2,647.58% | -2,734.35% | -843.49% |
| Total Depreciation and Amortization | 43.32% | 8.27% | -41.77% | -45.33% | -45.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 137.43% | 105.78% | 5,076.73% | 3,565.40% | 883.61% |
| Change in Net Operating Assets | -24.28% | 534.85% | -721.05% | -6.07% | -62.91% |
| Cash from Operations | -165.11% | -163.03% | -148.93% | -69.66% | -66.11% |
| Capital Expenditure | -4.01% | -6.32% | 4.16% | -2.69% | 10.82% |
| Sale of Property, Plant, and Equipment | 322.57% | 11.50% | -62.47% | -63.15% | -64.09% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -94.01% | -374.57% | -456.79% | -8.42% | -66.69% |
| Cash from Investing | 251.38% | 223.93% | -87.01% | -66.27% | -55.20% |
| Total Debt Issued | -9.97% | 38.69% | 153.24% | 285.42% | 495.59% |
| Total Debt Repaid | 21.93% | -15.58% | -95.03% | -201.11% | -322.48% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -477.25% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 87.07% | 77.60% | 326.45% | -237.57% | -454.51% |
| Cash from Financing | 164.16% | 170.28% | 195.20% | 54.38% | 3.54% |
| Foreign Exchange rate Adjustments | 406.95% | 310.43% | -70.18% | 696.98% | 189.62% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 231.27% | 204.06% | 83.48% | -451.11% | -212.66% |